✦ LIBER ✦

Previous use of quinolones: A surrogate marker for first line anti-tuberculosis drugs resistance in HIV-infected patients?

✍ Scribed by Deutschendorf, Caroline; Goldani, Luciano Z.; Pires dos Santos, Rodrigo

Book ID: 123362553
Publisher: SciELO
Year: 2012
Tongue: English
Weight: 114 KB
Volume: 16
Category: Article
ISSN: 1413-8670
DOI: 10.1016/S1413-8670(12)70295-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective study of drug-resistant tube

Prospective study of drug-resistant tuberculosis in a spanish urban population including patients at risk for HIV infection

✍ V. Ausina; N. Riutort; B. Viñado; J. M. Manterola; J. Ruiz Manzano; C. Rodrigo; 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 745 KB

Drug resistance among chronic HIV-1-infe

Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city

✍ Cláudio R. Gonsalez; Rosana Alcalde; Anna Nishiya; Claudia C. Barreto; Fabio E.S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Studies on the potential use of CD38 exp

Studies on the potential use of CD38 expression as a marker for the efficacy of anti-retroviral therapy in HIV-1-infected patients in Thailand

✍ Nattawat Onlamoon; Sutchana Tabprasit; Surapol Suwanagool; Suda Louisirirotchana 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 462 KB

Clinical and genetic risk factors for th

Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study

✍ S.K. Sharma; K.K. Turaga; A. Balamurugan; P.K. Saha; R.M. Pandey; N.K. Jain; V.M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Genetic susceptibility of the host to multi-drug resistant tuberculosis (MDR-TB) is not fully understood. We undertook a case-control study at a tertiary care center at New Delhi, India to identify the clinical and genetic predictors of MDR-TB as compared to the drug sensitive TB cases. Patients wit

Line probe assay (LiPA) for HIV-1 RT: Pr

Line probe assay (LiPA) for HIV-1 RT: Prevalence of drug-selected resistant isolates in HIV-1 infected VA patients: Stuyver, L.,1* Wyseur, A.,1 Rombout, A.,1 Rimland, D.,2 Rossau, R.,1 and Schinazi, R.F.2 Innogenetics NV, Gent, Belgium;1 and Georgia VA Res. Ctr. for AIDS and HIV Infections (RCAHI), VAMC/Emory University, Decatur, GA, USA2

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 112 KB